Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine? - Suppr | 超能文献

Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine?

作者信息

Solitano Virginia, Armuzzi Alessandro

机构信息

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

IBD Center, IRCCS Humanitas Research Hospital, Milan, Italy.

出版信息

Aliment Pharmacol Ther. 2022 Jul;56(2):347-348. doi: 10.1111/apt.17038.

DOI:10.1111/apt.17038

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis-a step towards precision medicine?

Aliment Pharmacol Ther. 2022 Jul;56(2):347-348. doi: 10.1111/apt.17038.

2

Tofacitinib in ulcerative colitis - In the era of precision medicine'.托法替布治疗溃疡性结肠炎——在精准医学时代

Dig Liver Dis. 2024 May;56(5):909-910. doi: 10.1016/j.dld.2024.01.188. Epub 2024 Feb 2.

3

Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis.在溃疡性结肠炎患者中，托法替尼治疗的 STAT3 磷酸化的纵向监测及其组织学结果。

Aliment Pharmacol Ther. 2022 Jul;56(2):282-291. doi: 10.1111/apt.16955. Epub 2022 Apr 28.

4

Refractory pediatric ulcerative colitis responding to high dose tofacitinib.难治性小儿溃疡性结肠炎对高剂量托法替布有反应。

Pediatr Int. 2023 Jan-Dec;65(1):e15551. doi: 10.1111/ped.15551.

5

Tofacitinib Inhibits Leukocyte Trafficking Across the Intestinal Endothelial Barrier in a Specific Cohort of Ulcerative Colitis Patients.托法替布在特定溃疡性结肠炎患者队列中抑制白细胞穿越肠道内皮屏障的迁移。

Inflamm Bowel Dis. 2022 Jun 3;28(6):971-976. doi: 10.1093/ibd/izab349.

6

A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.一例结节性红斑合并溃疡性结肠炎患者经托法替布治疗后病情缓解。

Dermatol Ther. 2022 Dec;35(12):e15963. doi: 10.1111/dth.15963. Epub 2022 Nov 10.

7

Efficacy of tofacitinib treatment in ulcerative colitis.托法替布治疗溃疡性结肠炎的疗效。

Gastroenterol Hepatol. 2019 Jun-Jul;42(6):403-412. doi: 10.1016/j.gastrohep.2019.03.002. Epub 2019 May 14.

8

Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?社论：托法替布是急性重症溃疡性结肠炎的另一种挽救治疗选择吗？

Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. doi: 10.1111/apt.16482.

9

Impaired IFN-γ-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.溃疡性结肠炎患者单核细胞中 IFN-γ 依赖性 STAT3 激活受损与调节和炎症信号失调有关。

Inflamm Bowel Dis. 2021 May 17;27(6):887-901. doi: 10.1093/ibd/izaa280.

10

Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.托法替布用于治疗溃疡性结肠炎、全秃和特应性皮炎：一种药物，三种疾病。

Inflamm Bowel Dis. 2021 Jan 19;27(2):e13-e14. doi: 10.1093/ibd/izaa243.

引用本文的文献

1

Translational, Precision, and Personalized Medicine in Gastroenterology.胃肠病学中的转化、精准和个性化医学。

Int J Mol Sci. 2022 Jul 25;23(15):8201. doi: 10.3390/ijms23158201.